Effects on Oral Squamous Carcinoma Cell Lines and Their Mechanisms of Pyrazole N-Aryl Sulfonate: A Novel Class of Selective Cyclooxygenase-2 Inhibitors
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26188906 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shiqi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Dental Maxillofacial Reconstruction and Biological Intelligence Manufacturing, School of Stomatology, Lanzhou University, Lanzhou 7…. Hauptthemen laut MEDLINE: Pyrazoles, Mouth Neoplasms, Cyclooxygenase 2 Inhibitors, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Research and Development Program of Gansu Province (International Scientific and Technological Cooperation Category), the Gansu Province Joint Research Fund, the Lanzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a highly aggressive malignancy with limited effective treatment options. This study aimed to explore the therapeutic potential of novel pyrazole N-aryl sulfonate derivatives (compounds 4b, 4d, and 5f) as selective cyclooxygenase-2 (COX-2; prostaglandin-endoperoxide synthase 2, PTGS2) inhibitors in OSCC. Using CCK-8 and Transwell assays, we evaluated the anti-proliferative and anti-migratory effects of these compounds on CAL-27 and SAS cell lines, while apoptosis was assessed by Hoechst 33342 staining and flow cytometry. Molecular mechanisms were investigated through RT-qPCR, Western blot, and ELISA, focusing on COX-2, MMP2, MMP9, BCL2, BAX, and the JAK/STAT3 pathway. The results demonstrated that compounds 4b, 4d, and 5f significantly inhibited cell proliferation and migration, induced apoptosis, and downregulated the expression of COX-2 and its downstream targets. Notably, these compounds exhibited lower cytotoxicity in VERO cells, indicating favorable biological safety. In conclusion, our findings suggest that pyrazole N-aryl sulfonate derivatives effectively suppress OSCC cell growth and migration by targeting COX-2 and the JAK/STAT3 pathway, highlighting their promise as potential targeted therapeutics for OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Dental Maxillofacial Reconstruction and Biological Intelligence Manufacturing, School of Stomatology, Lanzhou University, Lanzhou 730030, China.
- Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730030, China.
ORCID-Profile: Mingxuan Shi, Yi Li
Förderung
- the Key Research and Development Program of Gansu Province (International Scientific and Technological Cooperation Category)
- the Gansu Province Joint Research Fund
- the Lanzhou Science and Technology Plan Project
- the Foundation of Hospital of Stomatology, Lanzhou University
- Key Research and Development Program of Gansu Province
- Gansu Province Joint Research Fund
- Lanzhou Science and Technology Plan Project
- Foundation of Hospital of Stomatology, Lanzhou University
Zitieren
APA
Wang, S., Shi, M., Wang, H., Zeng, X., Zhang, D., Zhang, Z., Xu, Z., & Li, Y. (2025). Effects on Oral Squamous Carcinoma Cell Lines and Their Mechanisms of Pyrazole N-Aryl Sulfonate: A Novel Class of Selective Cyclooxygenase-2 Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188906
Vancouver
Wang S, Shi M, Wang H, Zeng X, Zhang D, Zhang Z, et al. Effects on Oral Squamous Carcinoma Cell Lines and Their Mechanisms of Pyrazole N-Aryl Sulfonate: A Novel Class of Selective Cyclooxygenase-2 Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188906
BibTeX
@article{Wang2025,
author = {Wang, Shiqi and Shi, Mingxuan and Wang, Huihui and Zeng, Xianlin and Zhang, Dingtai and Zhang, Zhiyuan and Xu, Zhaoqing and Li, Yi},
title = {Effects on Oral Squamous Carcinoma Cell Lines and Their Mechanisms of Pyrazole N-Aryl Sulfonate: A Novel Class of Selective Cyclooxygenase-2 Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26188906}
}
EUVIMED